Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support–free days in patients hospitalized with COVID-19: a randomized … S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, K Fareed, ... Jama 329 (14), 1183-1196, 2023 | 42 | 2023 |
Defining the incidence of cutaneous squamous cell carcinoma in coastal NSW Australia A Wilson, D Goltsman, J Nankervis, J Clark, R Gupta, B Ashford Australasian Journal of Dermatology, 2022 | 16 | 2022 |
Psoriasis and osteoporosis: a literature review D Wi, A Wilson, F Satgé, DF Murrell Clinical and Experimental Dermatology 47 (8), 1438-1445, 2022 | 12* | 2022 |
Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: a cohort study Y Liang, FAP Zeng, T Sheriff, A Wilson, A Bilgic, G Feng, JH Stone, ... JAAD international 6, 68-76, 2022 | 9 | 2022 |
Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: a systematic review FAP Zeng, A Wilson, T Sheriff, DF Murrell JAAD international 9, 33-43, 2022 | 8 | 2022 |
A novel airway management strategy for cervical necrotising fasciitis secondary to Bezold’s abscess S Al-Zahid, D Izadi, CJ Day, A Wilson, C Stone, J Smith The Annals of The Royal College of Surgeons of England 101 (1), e23-e25, 2019 | 6 | 2019 |
Pemphigus scoring systems and their validation studies–A review of the literature D Boucher, A Wilson, DF Murrell Dermatologica Sinica 41 (2), 67-77, 2023 | 3 | 2023 |
Clinical features of chronic bullous dermatosis of childhood A Wilson, DF Murrell Clinical and Experimental Dermatology 47 (5), 873-881, 2022 | 3 | 2022 |
Tildrakizumab for the treatment of hidradenitis suppurativa in patients previously treated with adalimumab: a 30-month experience B Koszegi, A Wilson, C Stone, F Satgé, TL Cowan, DF Murrell Clinical and Experimental Dermatology 48 (11), 1266-1269, 2023 | 2 | 2023 |
A Review of the Scoring and Assessment of Keratosis Pilaris MA Wang, A Wilson, DF Murrell Skin Appendage Disorders 9 (4), 241-251, 2023 | 2 | 2023 |
Intralesional 9‐valent human papillomavirus as a treatment for facial squamous cell carcinoma. A Wilson, TL Cowan, D Marucci, DF Murrell Journal of the European Academy of Dermatology & Venereology 36 (12), 2022 | 2 | 2022 |
Mental health, insomnia and suicidal ideation during treatment with apremilast TL Cowan, A Wilson, DF Murrell The Australasian Journal of Dermatology 63 (3), 403, 2022 | 2 | 2022 |
The dangers of social media: patients with atopic dermatitis ceasing their basic treatment A Wilson, TL Cowan, ADL Rivero, DF Murrell Clinical and Experimental Dermatology 48 (2), 142-143, 2023 | 1 | 2023 |
Severe bullous pemphigoid and IgA vasculitis secondary to Astrazeneca COVID-19 vaccination T Cowan, C Huang, A Wilson, D Murrell Australasian Journal of Dermatology 63, 19-19, 2022 | 1 | 2022 |
Complication rates of completion lymphadenectomy following positive sentinel lymph node biopsy versus therapeutic lymphadenectomy in melanoma JRO Smith, A Wilson, C Stone Journal of Plastic, Reconstructive & Aesthetic Surgery 69 (7), 1011-1012, 2016 | 1 | 2016 |
The development and validation of an investigator global assessment score for keratosis pilaris MA Wang, A Wilson, D Boucher, JS Johal, NK Rosenthal, T Cowan, ... Journal of the European Academy of Dermatology and Venereology: JEADV, 2024 | | 2024 |
396 A novel investigator global assessment score for the evaluation of keratosis pilaris MA Wang, A Wilson, B Daniel, ADL Rivero, L Martin, JS Kern, D Murrell Journal of Investigative Dermatology 143 (5), S68, 2023 | | 2023 |
390 Examining the risk factors for worsened glucocorticoid morbidity in a prospective, multicentre, international study of patients with autoimmune blistering diseases J Johal, T Cowan, A Bilgic, B Bozca, S Enli, B Yang, M Daneshpazhooh, ... Journal of Investigative Dermatology 143 (5), S67, 2023 | | 2023 |
Median canaliform nail dystrophy in a 2‐year‐old boy: Case report and review of the literature A Wilson, M Tariq Khan, DF Murrell Pediatric Dermatology 40 (3), 511-518, 2023 | | 2023 |
Tildrakizumab for the treatment of exfoliative cheilitis T Cowan, NA Alrub, A Wilson, M Makhija, D Murrell Mucosa 6 (1), 19-21, 2023 | | 2023 |